News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Features World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard Shelley Wood December 13, 2021
News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Daily News As Amyloidosis Field Explodes, Physicians Need to Spot and Treat Todd Neale October 20, 2021
News Daily News Higher CV Mortality Among More Socially Vulnerable US Adults Yael L. Maxwell October 20, 2021
News Daily News Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines Todd Neale October 06, 2021
News Daily News Big Impact Anticipated With HFpEF Expansion of Sacubitril/Valsartan Label Todd Neale September 20, 2021
News Conference News HFSA 2021 PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF Todd Neale September 13, 2021
News Daily News CMS Pays More to Male Cardiologists, but the Reasons Why Are Murky Michael O'Riordan September 10, 2021
News Daily News From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide L.A. McKeown September 06, 2021
News Conference News ESC 2021 In HFrEF, AI Shows Promise For Predicting Beta Blocker Response Yael L. Maxwell September 03, 2021
News Conference News ESC 2021 AV Junction Ablation Plus CRT Cuts Deaths in Permanent AF Subset Todd Neale September 01, 2021
News Conference News ESC 2021 EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF Todd Neale August 27, 2021
News Daily News Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited Michael O'Riordan August 03, 2021
News Daily News Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map Shelley Wood June 11, 2021
News Conference News ACC 2021 Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF Michael O'Riordan May 25, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Conference News ACC 2021 REHAB-HF: Tailored Cardiac Rehab Promotes Physical Function After Hospital Stay Caitlin E. Cox May 16, 2021